Micafungin
Top View
- Novel Antifungal Activity of Geraniol and Its Synergistic Effect in Combination with Fluconazole Against Resistant Candida Albicans
- New (& Nearly New) Antifungal Drugs for Coccidioidomycosis
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- Synergistic Activity of Micafungin Plus Voriconazole Against Multidrug-Resistant Candida Auris
- Guidelines for Treatment of Candidemia in Adults
- Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Novel Small Molecule Antifungals for Invasive Fungal Infections
- Estonian Statistics on Medicines 2017 1/42
- Antifungal Drug Repurposing
- Mycamine (Micafungin) Policy Number: C9347-A
- Antifungals of the Azole Type
- Evaluation of Carcinogenicity Studies of Medicinal Products for Human Use Authorised Via the European Centralised Procedure
- Department of Health & Human Services
- MYCAMINE® (Micafungin for Injection), for Intravenous Use ------CONTRAINDICATIONS ------Initial U.S
- Essential Medicines, Medical Countermeasures, and Critical Inputs for the List Described in Section 3(C) of the Executive Order 13944
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- Pythiosis: a Therapeutic Approach